(2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine

C21H33N5O3 — CID 131709814

IUPAC(2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine
SMILESCCC1(OC2CCC3NNC(c4cc(N5CCO[C@H](C)C5)ncn4)C3C2)COC1
InChIInChI=1S/C21H33N5O3/c1-3-21(11-27-12-21)29-15-4-5-17-16(8-15)20(25-24-17)18-9-19(23-13-22-18)26-6-7-28-14(2)10-26/h9,13-17,20,24-25H,3-8,10-12H2,1-2H3/t14-,15?,16?,17?,20?/m1/s1
InChIKeyBVNLPPZZPGCQML-ZIUDEIKKSA-N
MW403.53 g/mol
LogP1.58
Rot. Bonds5

About (2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine

(2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine (PubChem CID 131709814) has the molecular formula C21H33N5O3 and a molecular weight of 403.53 g/mol. Its IUPAC name is (2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine.

Molecular Properties

Compound Name(2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine
PubChem CID131709814
Molecular FormulaC21H33N5O3
Molecular Weight403.53 g/mol
Exact Mass403.26
IUPAC Name(2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine
SMILESCCC1(OC2CCC3NNC(c4cc(N5CCO[C@H](C)C5)ncn4)C3C2)COC1
InChIInChI=1S/C21H33N5O3/c1-3-21(11-27-12-21)29-15-4-5-17-16(8-15)20(25-24-17)18-9-19(23-13-22-18)26-6-7-28-14(2)10-26/h9,13-17,20,24-25H,3-8,10-12H2,1-2H3/t14-,15?,16?,17?,20?/m1/s1
InChIKeyBVNLPPZZPGCQML-ZIUDEIKKSA-N
XLogP1.58
TPSA80.77 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500403.53
LogP ≤ 51.58
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze (2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine?
The IUPAC name of (2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine (CID 131709814) is (2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine.
What is the SMILES notation for (2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine?
The canonical SMILES for (2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine is CCC1(OC2CCC3NNC(c4cc(N5CCO[C@H](C)C5)ncn4)C3C2)COC1.
What is the InChIKey of (2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine?
The InChIKey is BVNLPPZZPGCQML-ZIUDEIKKSA-N. The full InChI is InChI=1S/C21H33N5O3/c1-3-21(11-27-12-21)29-15-4-5-17-16(8-15)20(25-24-17)18-9-19(23-13-22-18)26-6-7-28-14(2)10-26/h9,13-17,20,24-25H,3-8,10-12H2,1-2H3/t14-,15?,16?,17?,20?/m1/s1.
What are the key properties of (2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine?
(2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine has a molecular weight of 403.53 g/mol, XLogP of 1.58, 5 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-4-[6-[5-(3-ethyloxetan-3-yl)oxy-2,3,3a,4,5,6,7,7a-octahydro-1H-indazol-3-yl]pyrimidin-4-yl]-2-methylmorpholine is sourced from PubChem (CID 131709814), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).